A Multicenter, Open-Label Phase 1b/2 Study of Ibrutinib

Project: Research project

Project Details

Description

A Multicenter, Open-Label Phase 1b/2 Study of Ibrutinib for Steroid Dependent or Refractory Chronic Graft Versus Host Disease
StatusFinished
Effective start/end date6/1/148/30/19

Funding

  • PHARMACYCLICS, INC.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.